Table 1.
Clinico-pathological characteristics of CRC patients from training set included in the study.
| Characteristics | N (%) | Characteristics | N (%) |
|---|---|---|---|
| Median Age (range) | 64 years (37–83) | Mestastasic disease | |
| Gender | Synchronous | 23 (66%) | |
| Female | 13 (37%) | Metachronous | 12 (34%) |
| Male | 18 (52%) | Differentiation grade | |
| N/A | 4 (11%) | Well | 9 (26%) |
| Family history of cancer | Moderate | 16 (46%) | |
| No | 25 (72%) | Poor | 3 (8%) |
| Yes | 5 (14%) | N/A | 7 (20%) |
| N/A | 5 (14%) | Inflammation | |
| Localization of primary tumor | No | 11 (32%) | |
| Right | 6 (17%) | Low | 14 (40%) |
| Transverse | 2 (6%) | Moderate | 4 (11%) |
| Left | 2 (6%) | N/A | 6 (17%) |
| Sigma | 11 (32%) | Vascular Invasion | |
| Rectum | 8 (23%) | No | 25 (72%) |
| Cecum | 3 (8%) | Yes | 4 (11%) |
| N/A | 3 (8%) | N/A | 6 (17%) |
| pT | MMR | ||
| T1 | 2 (6%) | Deficient | 3 (9%) |
| T2 | 2 (6%) | Proficient | 29 (82%) |
| T3 | 29 (82%) | N/A | 3 (9%) |
| T4 | 1 (3%) | RAS status | |
| N/A | 1 (3%) | wild-type | 24 (69%) |
| pN | Mutated | 6 (17%) | |
| N0 | 18 (52%) | N/A | 5 (14%) |
| N1 | 11 (31%) | UNR | |
| N2 | 5 (14%) | High | 14 (40%) |
| N/A | 1 (3%) | Low | 21 (60%) |
N: number of patients; pT: tumor infiltration; pN: lymph node involvement; MMR: mismatch-repair gene status; N/A: not available.